Investigating long-term effects of COVID-19 recovery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term sequelae of SARS-CoV-2 infection in patients who have recovered from COVID-19. It focuses on assessing various potential complications, including endocrine, metabolic, neuropsychiatric, muscular, pulmonary, cardiovascular, and dermatological issues. Patients will be evaluated at baseline upon discharge and again after 3 to 12 months to determine the prevalence and types of these complications. The findings could significantly enhance therapeutic management and long-term follow-up for these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of both sexes recovered from SARS-CoV-2 infection (two negative nasopharyngeal swabs, negative IgM and positive anti SARS-CoV-2 IgG);
* Aged over 18 years of age;
* Ability to understand protocol procedures

Exclusion Criteria:

* Any psychological/psychiatric/other medical conditions compromising the understanding of the nature and purpose of the study, and of its possible consequences
* uncooperative attitude of the patient

Where it's running

• Federico II University of Naples
  Naples, Italy Recruiting

Study contacts

• Principal investigator: Annamaria Colao, Prof — Federico II University
• Study coordinator: Annamaria Colao, Prof
• Email: colao@unina.it
• Phone: 3285390000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Anktiva for treating Long COVID symptoms

  This will test whether Anktiva helps adults aged 18–69 who had confirmed COVID-19 and now have persistent or worsened Long COVID symptoms.

  Recruiting Phase 2 ImmunityBio, Inc. · El Segundo, California · NCT07123727

• Low-dose sirolimus for adults with Long COVID (PASC)

  This trial will test whether low-dose sirolimus can reduce symptoms in adults who have had Long COVID for at least six months.

  Recruiting Phase 3 Icahn School of Medicine at Mount Sinai · New York, New York · NCT06960928

• Online treatment for emotional disorders in adults with long COVID-19

  This study is testing if an online treatment for emotional issues can help adults with long COVID-19 feel better compared to regular care.

  Recruiting Instituto de Investigación Sanitaria Aragón · Zaragoza, Zaragoza and 1 other locations · NCT06928480

• Investigating neurological complications of long COVID in children and adolescents

  This study is trying to understand how long COVID affects the brains of children and teens aged 6 to 16 by looking at their symptoms and brain activity after they've had the virus.

  Recruiting Azienda Ospedaliero, Universitaria Pisana · Pisa, PI · NCT06876948

• Rehabilitation program to reduce fatigue after COVID-19

  This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06156176

• Investigating long-term effects of COVID-19 on male and female reproductive health

  This study is trying to see how COVID-19 affects the reproductive health and sexual function of men and women after they recover from the virus.

  Recruiting Federico II University · Naples, Italy · NCT05379556

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.